Pulmonary Reactions Associated with Amphotericin B and Leukocyte Transfusions

Stephen J. Forman, Gayle V. Robinson, Jeffrey L. Wolf, Wayne E. Spruce, Karl G. Blume, Michael W. Degregorio, William M.F. Lee, Curt A. Ries, Daniel G. Wright, Kay Robichaud, Philip A. Pizzo, Albert B. Deisseroth

Research output: Contribution to journalLetter

13 Citations (Scopus)

Abstract

To the Editor: At the City of Hope National Medical Center, we have had substantial experience with the use of granulocytes and amphotericin B as part of our bone-marrow transplantation program for hematologic cancers. Our experience is considerably different from that reported by Wright and his co-workers in the May 14 issue.* Between May 1976 and May 1981, 95 patients with hematologic cancer underwent bone-marrow transplantation. The first 77 patients received prophylactic granulocyte support when the white-cell count fell below 500 per microliter, and they continued to receive this support until the count was above 500 per microliter (nine to.

Original languageEnglish (US)
Pages (from-to)584-585
Number of pages2
JournalNew England Journal of Medicine
Volume305
Issue number10
DOIs
StatePublished - Sep 3 1981

Fingerprint

Leukocyte Transfusion
Amphotericin B
Bone Marrow Transplantation
Granulocytes
Bone Neoplasms
Lung
Cell Count
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Forman, S. J., Robinson, G. V., Wolf, J. L., Spruce, W. E., Blume, K. G., Degregorio, M. W., ... Deisseroth, A. B. (1981). Pulmonary Reactions Associated with Amphotericin B and Leukocyte Transfusions. New England Journal of Medicine, 305(10), 584-585. https://doi.org/10.1056/NEJM198109033051019

Pulmonary Reactions Associated with Amphotericin B and Leukocyte Transfusions. / Forman, Stephen J.; Robinson, Gayle V.; Wolf, Jeffrey L.; Spruce, Wayne E.; Blume, Karl G.; Degregorio, Michael W.; Lee, William M.F.; Ries, Curt A.; Wright, Daniel G.; Robichaud, Kay; Pizzo, Philip A.; Deisseroth, Albert B.

In: New England Journal of Medicine, Vol. 305, No. 10, 03.09.1981, p. 584-585.

Research output: Contribution to journalLetter

Forman, SJ, Robinson, GV, Wolf, JL, Spruce, WE, Blume, KG, Degregorio, MW, Lee, WMF, Ries, CA, Wright, DG, Robichaud, K, Pizzo, PA & Deisseroth, AB 1981, 'Pulmonary Reactions Associated with Amphotericin B and Leukocyte Transfusions', New England Journal of Medicine, vol. 305, no. 10, pp. 584-585. https://doi.org/10.1056/NEJM198109033051019
Forman SJ, Robinson GV, Wolf JL, Spruce WE, Blume KG, Degregorio MW et al. Pulmonary Reactions Associated with Amphotericin B and Leukocyte Transfusions. New England Journal of Medicine. 1981 Sep 3;305(10):584-585. https://doi.org/10.1056/NEJM198109033051019
Forman, Stephen J. ; Robinson, Gayle V. ; Wolf, Jeffrey L. ; Spruce, Wayne E. ; Blume, Karl G. ; Degregorio, Michael W. ; Lee, William M.F. ; Ries, Curt A. ; Wright, Daniel G. ; Robichaud, Kay ; Pizzo, Philip A. ; Deisseroth, Albert B. / Pulmonary Reactions Associated with Amphotericin B and Leukocyte Transfusions. In: New England Journal of Medicine. 1981 ; Vol. 305, No. 10. pp. 584-585.
@article{347d795a5bc34fcf9abf212321c8f4b4,
title = "Pulmonary Reactions Associated with Amphotericin B and Leukocyte Transfusions",
abstract = "To the Editor: At the City of Hope National Medical Center, we have had substantial experience with the use of granulocytes and amphotericin B as part of our bone-marrow transplantation program for hematologic cancers. Our experience is considerably different from that reported by Wright and his co-workers in the May 14 issue.* Between May 1976 and May 1981, 95 patients with hematologic cancer underwent bone-marrow transplantation. The first 77 patients received prophylactic granulocyte support when the white-cell count fell below 500 per microliter, and they continued to receive this support until the count was above 500 per microliter (nine to.",
author = "Forman, {Stephen J.} and Robinson, {Gayle V.} and Wolf, {Jeffrey L.} and Spruce, {Wayne E.} and Blume, {Karl G.} and Degregorio, {Michael W.} and Lee, {William M.F.} and Ries, {Curt A.} and Wright, {Daniel G.} and Kay Robichaud and Pizzo, {Philip A.} and Deisseroth, {Albert B.}",
year = "1981",
month = "9",
day = "3",
doi = "10.1056/NEJM198109033051019",
language = "English (US)",
volume = "305",
pages = "584--585",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "10",

}

TY - JOUR

T1 - Pulmonary Reactions Associated with Amphotericin B and Leukocyte Transfusions

AU - Forman, Stephen J.

AU - Robinson, Gayle V.

AU - Wolf, Jeffrey L.

AU - Spruce, Wayne E.

AU - Blume, Karl G.

AU - Degregorio, Michael W.

AU - Lee, William M.F.

AU - Ries, Curt A.

AU - Wright, Daniel G.

AU - Robichaud, Kay

AU - Pizzo, Philip A.

AU - Deisseroth, Albert B.

PY - 1981/9/3

Y1 - 1981/9/3

N2 - To the Editor: At the City of Hope National Medical Center, we have had substantial experience with the use of granulocytes and amphotericin B as part of our bone-marrow transplantation program for hematologic cancers. Our experience is considerably different from that reported by Wright and his co-workers in the May 14 issue.* Between May 1976 and May 1981, 95 patients with hematologic cancer underwent bone-marrow transplantation. The first 77 patients received prophylactic granulocyte support when the white-cell count fell below 500 per microliter, and they continued to receive this support until the count was above 500 per microliter (nine to.

AB - To the Editor: At the City of Hope National Medical Center, we have had substantial experience with the use of granulocytes and amphotericin B as part of our bone-marrow transplantation program for hematologic cancers. Our experience is considerably different from that reported by Wright and his co-workers in the May 14 issue.* Between May 1976 and May 1981, 95 patients with hematologic cancer underwent bone-marrow transplantation. The first 77 patients received prophylactic granulocyte support when the white-cell count fell below 500 per microliter, and they continued to receive this support until the count was above 500 per microliter (nine to.

UR - http://www.scopus.com/inward/record.url?scp=0019857016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019857016&partnerID=8YFLogxK

U2 - 10.1056/NEJM198109033051019

DO - 10.1056/NEJM198109033051019

M3 - Letter

VL - 305

SP - 584

EP - 585

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 10

ER -